We have posted "financial results presentation for the second quarter ended September 30, 2019".

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

Consolidated Financial Statements for the Second Quarter Ended September 30, 2019 FY2020 (April 1, 2019 – March 31, 2020)[UNAUDITED]

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

GE Healthcare Launches Edison Datalogue to Help Health Systems Break Down Siloes and Improve the Care Experience

CHICAGO – NOVEMBER 7, 2019 – GE Healthcare today launched Edison™ Datalogue™, a new enterprise data management solution, aimed at connecting data systems, devices, applications and clinicians to give health systems a more holistic view of their data, ultimately to help improve clinical and financial outcomes. The new offering combines GE Healthcare’s vendor neutral archive... Read more

Brooks Automation Reports Fourth Quarter and Year-End Results of Fiscal Year 2019, Ended September 30, 2019, and Announces Quarterly Cash Dividend

Brooks Automation Reports Fourth Quarter and Year-End Results of Fiscal Year 2019, Ended September 30, 2019, and Announces Quarterly Cash Dividend Revenue Growth at 24% Caps Off a Transformative Year of High Growth and Margin Expansion CHELMSFORD, Mass., Nov. 6, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS), a leader in automation solutions for the semiconductor... Read more

Roche to present new data highlighting breadth of haematology portfolio and pipeline at the American Society of Hematology 2019 Annual Meeting

Basel, 06 November 2019 Roche to present new data highlighting breadth of haematology portfolio and pipeline at the American Society of Hematology 2019 Annual Meeting Ten Roche medicines will be featured in more than 70 abstracts and 21 oral presentations, across a range of 15 blood cancers and non-malignant haematological conditions New data for CD20-CD3... Read more

Nalgene Outdoor Launches New Bottle Customization Feature

“Customizer” Shop Offers One-of-a-Kind Bottles; Creates Unique Water Bottles That Reflect Personal Styles ROCHESTER, N.Y., Nov. 6, 2019 /PRNewswire/ — Nalgene Outdoor, maker of reusable water bottles, launches its new “Customizer” online store , which offers Nalgene bottle fans a way to create individualized products quickly and easily– the perfect companion for everyday adventures! Nalgene Outdoor’s... Read more

GE Healthcare Life Sciences and Akeso Pharmaceuticals to speed up novel therapy manufacturing in China

GE Healthcare Life Sciences will supply Akeso Pharmaceuticals with the FlexFactory™ platform to accelerate the production of antibody drugs in the Guangzhou region Expected to be operational by end of 2020 and create up to 150 jobs upon opening. November 6, 2019 – Uppsala, Sweden and Guangzhou, China – Akeso Pharmaceuticals, a biotech company specializing... Read more

QIAGEN expands portfolio of immuno-oncology assets for future companion diagnostics and biomarkers

Collaborates with Repertoire Genesis for access to T-cell /B-cell receptor repertoire assays for clinical next-generation sequencing Acquires licensing rights for epigenomic (DNA methylation) immune checkpoint inhibitor biomarkers developed by researchers from the University of Bonn Receives exclusive license to novel mRNA gene expression signatures from STRATIFYER Molecular Pathology GmbH which may guide treatment decisions for... Read more

BD Announces Results For 2019 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2020 Guidance

FRANKLIN LAKES, N.J., Nov. 5, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.584 billion for the fourth fiscal quarter ended September 30, 2019.  This represents an increase of 4.1 percent over the prior-year period.  On a comparable, currency-neutral basis, revenues increased 6.2 percent... Read more

Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA

AUSTIN, Texas, Nov. 4, 2019 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2019. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”).  Comparisons shown in this release are to the same period in the prior year unless otherwise noted. CURRENT... Read more